- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of GILEAD SCIENCES, INC.
- Signature - Title
- /s/ Andrew D. Dickinson - Andrew D. Dickinson/Chief Financial Officer
- Location
- Foster City, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by GILEAD SCIENCES, INC..
Follow Filing Activity
Follow GILEAD SCIENCES, INC. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of GILEAD SCIENCES, INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GLPG | Galapagos NV | Ordinary Shares, no par value | 30% | $555,786,955 | 20,981,010 | Gilead Sciences, Inc. | 07 Jan 2025 | ||
| ASMB | ASSEMBLY BIOSCIENCES, INC. | Common Stock, par value $0.001 | 29% | 4,505,391 | +104% | GILEAD SCIENCES, INC. | 08 Aug 2025 | ||
| RCUS | Arcus Biosciences, Inc. | Common Stock, par value $0.0001 | 26% | $427,376,736 | 31,424,760 | 0% | GILEAD SCIENCES, INC. | 03 Nov 2025 | |
| XLO | Xilio Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 20% | $9,581,667 | +$2,576,464 | 14,517,678 | +37% | GILEAD SCIENCES, INC. | 31 Dec 2025 |
| ACLX | Arcellx, Inc. | Common Stock, par value $0.001 | 12% | $457,955,516 | 6,720,803 | Gilead Sciences, Inc. | 23 Feb 2026 | ||
| KLRS | Kalaris Therapeutics, Inc. | Common Stock, $0.0001 per value | 3.9% | $4,715,740 | 723,273 | GILEAD SCIENCES, INC. | 18 Mar 2025 | ||
| IKNA | Ikena Oncology, Inc. | Common Stock | 3.6% | $1,612,591 | 1,521,312 | GILEAD SCIENCES INC | 31 Dec 2024 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | GILEAD SCIENCES, INC. | 31 Dec 2025 |
Schedules 13D/G Reported by GILEAD SCIENCES, INC.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.